These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28961281)

  • 21. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet.
    Stepankova R; Tonar Z; Bartova J; Nedorost L; Rossman P; Poledne R; Schwarzer M; Tlaskalova-Hogenova H
    J Atheroscler Thromb; 2010 Aug; 17(8):796-804. PubMed ID: 20379054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
    Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L
    Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
    Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(-/-) mice.
    Chen J; Cao J; Fang L; Liu B; Zhou Q; Sun Y; Wang Y; Li Y; Meng S
    J Transl Med; 2014 Nov; 12():326. PubMed ID: 25425200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
    Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
    Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Betulin attenuates atherosclerosis in apoE
    Gui YZ; Yan H; Gao F; Xi C; Li HH; Wang YP
    Acta Pharmacol Sin; 2016 Sep; 37(10):1337-1348. PubMed ID: 27374487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice.
    Tian GP; Tang YY; He PP; Lv YC; Ouyang XP; Zhao GJ; Tang SL; Wu JF; Wang JL; Peng J; Zhang M; Li Y; Cayabyab FS; Zheng XL; Zhang DW; Yin WD; Tang CK
    Biochem Biophys Res Commun; 2014 Jan; 443(2):428-34. PubMed ID: 24309104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the Ubiquitin-Activating Enzyme UBA1 Suppresses Diet-Induced Atherosclerosis in Apolipoprotein E-Knockout Mice.
    Liao J; Yang X; Lin Q; Liu S; Xie Y; Xia Y; Li HH
    J Immunol Res; 2020; 2020():7812709. PubMed ID: 32258175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
    Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H
    Circulation; 2004 Nov; 110(22):3493-500. PubMed ID: 15557373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
    Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound Biomicroscopic Imaging for Interleukin-1 Receptor Antagonist-Inhibiting Atherosclerosis and Markers of Inflammation in Atherosclerotic Development in Apolipoprotein-E Knockout Mice.
    Li RJ; Sun Y; Wang Q; Yang J; Yang Y; Song L; Wang Z; Luo XH; Su RJ
    Tex Heart Inst J; 2015 Aug; 42(4):319-26. PubMed ID: 26413013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-atherosclerotic effects of Polygonum aviculare L. ethanol extract in ApoE knock-out mice fed a Western diet mediated via the MAPK pathway.
    Haeng Park S; Sung YY; Jin Nho K; Kyoung Kim H
    J Ethnopharmacol; 2014 Feb; 151(3):1109-1115. PubMed ID: 24370878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice].
    Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SAP deficiency mitigated atherosclerotic lesions in ApoE(-/-) mice.
    Zheng L; Wu T; Zeng C; Li X; Li X; Wen D; Ji T; Lan T; Xing L; Li J; He X; Wang L
    Atherosclerosis; 2016 Jan; 244():179-87. PubMed ID: 26649902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model.
    Madan M; Bishayi B; Hoge M; Amar S
    Atherosclerosis; 2008 Apr; 197(2):504-14. PubMed ID: 17412346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of some active ingredients of Chinese drugs for activating blood circulation and detoxicating on blood lipids and atherosclerotic plaque inflammatory reaction in ApoE-gene knockout mice].
    Zhou MX; Xu H; Chen KJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Feb; 28(2):126-30. PubMed ID: 18386574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.